ArticleMolecular oncology2023

Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC.

Caterina Carbonell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.